Skip to main content

letter

. 2005 Sep;64(9):1379–1380. doi: 10.1136/ard.2004.035030

Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab

P Ornetti, E Solau, P Gaudin, J Sibilia, J Berthelot, X Puechal, C Tavernier, J Maillefert, b on

PMCID: PMC1755656 PMID: 16100349

Full Text

The Full Text of this article is available as a PDF (63.4 KB).

percentage of patients with good and moderate response (EULAR criteria) 8 and 16 weeks after an increase in the MTX weekly dose.

ACTIONS

RESOURCES